VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
TARS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
TARSTarsus Pharmaceuticals, Inc.
$68.60$3.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksTARSQuarterly Balance Sheet

Tarsus Pharmaceuticals, Inc. (TARS) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Tarsus Pharmaceuticals, Inc. (TARS) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

TARS Balance Sheet

Quarterly statement

TARS Balance Sheet

Tarsus Pharmaceuticals, Inc. (TARS) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets445.42M561.99M537.23M522.78M501.7M474.43M480.77M356.7M357.12M362.59M340.72M256.13M259.28M183.48M208.65M225.38M234.08M250.28M178.75M175.95M
Cash & Short-Term Investments309.61M449.69M388.73M417.27M401.84M381.14M407.92M291.38M316.95M323.58M298.52M227.44M246.88M178.23M201.22M217.03M226.57M245.36M175.3M171.81M
Cash Only136.53M204.59M102.19M183.64M112.72M96.65M175.79M94.82M176.21M181.09M193.71M224.95M226.67M106.77M66M71.66M169.49M245.36M175.01M171.33M
Short-Term Investments173.08M245.09M286.54M233.63M289.11M284.5M232.13M196.56M140.74M142.49M104.82M2.5M20.21M71.45M135.22M145.37M57.08M0291K483K
Accounts Receivable102.11M98.31M117.21M87.11M74.34M60.24M64.15M48.06M30.3M30.84M31.36M17.71M6.37M246K2.92M3.58M4.01M620K323K92K
Days Sales Outstanding47.3856.3856.7448.9752.1555.1364.4654.2858.4569.3580.8684.72162.66-11734.93-2.8134.6531.44
Inventory5.16M4.38M4.57M4.37M3.84M3.87M2.71M2.62M2.85M2.19M4.04M3.11M15K0000000
Days Inventory Outstanding31.5733.6242.8434.5514.4247.9945.9851.0471.5394.38196.5118.13.66-------
Other Current Assets000560K0000000000000000
Total Non-Current Assets60.08M49.15M43.91M39.38M32.86M20.57M19.98M20.29M19.18M14.26M8.55M9.36M9.05M5.45M2.57M2.49M2.39M2.54M2.73M2.96M
Property, Plant & Equipment31.11M30.4M27.67M21.75M15.98M3.41M3.18M2.87M4.2M4.21M3.47M3.35M3.63M3.68M1.73M1.53M1.65M1.78M1.84M1.83M
Fixed Asset Turnover6.33x5.99x6.56x8.04x12.24x31.15x25.91x18.81x11.45x10.63x8.10x3.75x0.51x-1.53x6.29x-8.45x0.29x0.19x
Goodwill00000000000000000000
Intangible Assets16.64M6.88M7.13M7.37M7.61M7.85M8.09M8.33M8.57M3.67M3.77M3.87M3.97M0000000
Long-Term Investments6.68M6.68M5.87M3.87M5.56M3M3M3M3M3M0631K210K322K306K371K157K169K00
Other Non-Current Assets5.64M5.19M3.24M6.39M3.71M6.31M5.71M6.09M3.42M3.38M1.32M1.51M1.25M1.45M529K585K583K600K887K1.13M
Total Assets505.5M611.14M581.13M562.16M534.56M494.99M500.75M376.99M376.3M376.84M349.28M265.49M268.33M188.93M211.21M227.86M236.47M252.83M181.48M178.91M
Asset Turnover0.35x0.29x0.28x0.28x0.23x0.21x0.18x0.18x0.13x0.11x0.09x0.05x0.01x-0.01x0.04x-0.07x0.00x0.00x
Asset Growth %-5.44%23.46%16.05%49.12%42.06%31.35%43.37%42%40.24%99.47%65.37%16.51%13.48%-25.27%16.38%27.36%24.19%24.27%-6.43%4.03%
Total Current Liabilities227.11M175.75M143.51M135.69M117.05M90.25M86.31M80.61M65.87M51.57M42.53M36.94M23.25M14.77M13.26M15.43M14.27M11.72M12.61M11.48M
Accounts Payable34.69M40.14M24.13M16.39M40.64M28.07M28.38M27.74M26.82M26.65M19.14M17.77M10.38M8.17M7.57M5.5M5.59M4.09M4.03M2.86M
Days Payables Outstanding247.76241.42194.05240.08128.53411.87484.65509.44758.65693.631.02K1.07K2.26K2.27K2.31K1.28K2.11K707.869.39K-9.33K
Short-Term Debt000080K000000000000000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities192.42M133.51M110.28M117.5M62.78M00000000000012K25K56K
Current Ratio1.96x3.20x3.74x3.85x4.29x5.26x5.57x4.42x5.42x7.03x8.01x6.93x11.15x12.43x15.74x14.61x16.40x21.36x14.18x15.33x
Quick Ratio1.94x3.17x3.71x3.82x4.25x5.21x5.54x4.39x5.38x6.99x7.92x6.85x11.15x12.43x15.74x14.61x16.40x21.36x14.18x15.33x
Cash Conversion Cycle-168.81-151.42-94.48-156.56-61.96-308.75-374.2-404.11-628.67-529.91-738.11-862.21-2.1K-------
Total Non-Current Liabilities174.36M88.66M88.68M83.04M82.43M72.13M71.98M71.84M72.95M73.03M31.54M31.57M31.42M26.43M24.55M19.53M19.57M19.61M19.68M699K
Long-Term Debt72.94M72.76M72.6M83.04M72.28M72.13M71.98M71.84M71.71M71.58M29.93M29.82M29.71M24.61M24.52M19.43M19.36M19.26M19.18M0
Capital Lease Obligations15.73M15.89M16.08M10.6M10.15M000000000052K169K300K425K585K
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities85.69M00-10.6M00001.24M1.45M1.61M1.75M1.71M1.83M40K48K40K43K71K114K
Total Liabilities401.47M264.41M232.18M218.73M199.48M162.38M158.29M152.46M138.82M124.6M74.07M68.5M54.67M41.2M37.81M34.96M33.84M31.32M32.29M12.18M
Total Debt88.67M88.66M88.68M93.64M82.51M72.45M72.37M72.45M72.34M72.18M30.52M30.22M30.13M25.04M25.22M20.21M20.1M20.17M20.41M1.89M
Net Debt-47.86M-115.94M-13.52M-90M-30.21M-24.2M-103.42M-22.37M-103.87M-108.91M-163.19M-194.73M-196.54M-81.73M-40.78M-51.45M-149.39M-225.2M-154.6M-169.44M
Debt / Equity0.85x0.26x0.25x0.27x0.25x0.22x0.21x0.32x0.30x0.29x0.11x0.15x0.14x0.17x0.15x0.10x0.10x0.09x0.14x0.01x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-302.75x-6.34x-3.38x-1.85x-5.95x-8.64x-11.04x-9.57x-9.06x-14.78x-35.35x-41.37x-44.67x-37.56x-33.28x-18.65x-34.64x-9.56x-63.04x-
Total Equity104.03M346.73M348.95M343.43M335.08M332.61M342.46M224.53M237.48M252.25M275.21M196.99M213.66M147.73M173.4M192.9M202.63M221.5M149.2M166.73M
Equity Growth %-68.95%4.25%1.9%52.95%41.1%31.86%24.43%13.98%11.15%70.75%58.71%2.12%5.45%-33.31%16.22%15.7%13.11%15.08%-18.57%0.45%
Book Value per Share2.247.998.128.037.867.858.705.826.196.677.806.176.985.516.487.517.609.107.208.08
Total Shareholders' Equity104.03M346.73M348.95M343.43M335.08M332.61M342.46M224.53M237.48M252.25M275.21M196.99M213.66M147.73M173.4M192.9M202.63M221.5M149.2M166.73M
Common Stock7K6K6K6K6K6K6K6K6K6K6K5K5K5K5K5K5K5K4K4K
Retained Earnings-1.12B-452.15M-433.6M-426.63M-418.25M-405.67M-385.33M-360.21M-337.1M-313.68M-280.39M-244.66M-202.75M-163.61M-132.18M-108.76M-95.16M-72.65M-66.91M-46.67M
Treasury Stock00000000000000000000
Accumulated OCI-914K-557K-298K381K289K39K85K179K346K-176K-63K-2K-8K-23K-70K-74K-10K000
Minority Interest00000000000000000000